However, B cells remain significantly lower after 9 months, and memory CD4+ T cells exhibit an abnormal bias toward inflammatory effectors that persists for years, albeit in cohorts of breast cancer patients with mixed or unknown molecular subtypes63,64. Here, CD4 is linked to breast carcinoma.